The metabolic syndrome as a predictor of incident diabetes mellitus in Mauritius

Diabetic Medicine

Volumn 24, Issue 12, 2007, Pages 1460-1469

  Cameron, A J ^a   Zimmet, P Z ^a   Soderberg, S ^b   Alberti, K G M M ^c   Sicree, R ^a   Tuomilehto, J ^d,e   Chitson, P ^f   Shaw, J E ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b UMEÅ UNIVERSITY   (Sweden)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

^d NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^e UNIVERSITY OF HELSINKI   (Finland)

^f Ministry of Health and Quality of Life   (Mauritius)

Author keywords

Diabetes; Incidence; Mauritius; Metabolic syndrome; Prediction

Indexed keywords

ARTICLE; BLOOD PRESSURE; BODY MASS; DIABETES MELLITUS; GLUCOSE TOLERANCE; HUMAN; LONGITUDINAL STUDY; MAURITIUS; METABOLIC SYNDROME X; OBESITY; PREDICTION; SENSITIVITY AND SPECIFICITY; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

ADULT; BLOOD GLUCOSE; DIABETES MELLITUS; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MAURITIUS; METABOLIC SYNDROME X; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PREVALENCE; SENSITIVITY AND SPECIFICITY; WAIST-HIP RATIO;

EID: 36549066592     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2007.02288.x     Document Type: Article

References (30)

1. Laaksonen DE, Lakka HM, Niskanen LK, Kaplan GA, Salonen JT, Lakka TA. Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study. Am J Epidemiol 2002 156 : 1070 1077.
2. Lorenzo C, Okoloise M, Williams K, Stern MP, Haffner SM. The metabolic syndrome as predictor of type 2 diabetes: the San Antonio heart study. Diabetes Care 2003 26 : 3153 3159.
3. Sattar N, Gaw A, Scherbakova O, Ford I, O'Reilly DS, Haffner SM et al. Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation 2003 108 : 414 419.
4. Hanley AJ, Karter AJ, Williams K, Festa A, D'Agostino RB Jr., Wagenknecht LE et al. Prediction of type 2 diabetes mellitus with alternative definitions of the metabolic syndrome: the Insulin Resistance Atherosclerosis Study. Circulation 2005 112 : 3713 3721.
5. Stern MP, Williams K, Gonzalez-Villalpando C, Hunt KJ, Haffner SM. Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease? Diabetes Care 2004 27 : 2676 2681.
6. Wilson PW, D'Agostino RB, Parise H, Sullivan L, Meigs JB. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation 2005 112 : 3066 3072.
7. Wannamethee SG, Shaper AG, Lennon L, Morris RW. Metabolic syndrome vs Framingham Risk Score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus. Arch Intern Med 2005 165 : 2644 2650.
8. Schmidt MI, Duncan BB, Bang H, Pankow JS, Ballantyne CM, Golden SH et al. Identifying individuals at high risk for diabetes: The Atherosclerosis Risk in Communities study. Diabetes Care 2005 28 : 2013 2018.
9. Wang JJ, Qiao Q, Miettinen ME, Lappalainen J, Hu G, Tuomilehto J. The metabolic syndrome defined by factor analysis and incident type 2 diabetes in a Chinese population with high postprandial glucose. Diabetes Care 2004 27 : 2429 2437.
10. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. 2005 Circulation 112 : e285 e290.
11. World Health Organization. Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. Part 1: Diagnosis and Classification of Diabetes Mellitus. Geneva : Department of Non-Communicable Disease Surveillance, 1999.
12. Balkau B, Charles MA. Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet Med 1999 16 : 442 443.
13. Alberti KG, Zimmet P, Shaw J. The metabolic syndrome - a new worldwide definition. Lancet 2005 366 : 1059 1062.
14. Stern MP, Williams K, Haffner SM. Identification of persons at high risk for type 2 diabetes mellitus: do we need the oral glucose tolerance test? Ann Intern Med 2002 136 : 575 581.
15. Dowse G, Gareeboo H, Zimmet P, Alberti K, Tuomilehto J, Fareed D et al. High prevalence of NIDDM and impaired glucose tolerance in Indian, Creole and Chinese Mauritians. Diabetes 1990 39 : 390 396.
16. Dowse G, Gareeboo H, Alberti K, Zimmet P, Tuomilehto J, Purran A et al. Changes in population cholesterol concentrations and other cardiovascular risk factor levels after five years of the non-communicable disease intervention programme in Mauritius. Br Med J 1995 311 : 1255 1259.
17. Soderberg S, Zimmet P, Tuomilehto J, de Courten M, Dowse GK, Chitson P et al. Increasing prevalence of Type 2 diabetes mellitus in all ethnic groups in Mauritius. Diabet Med 2005 22 : 61 68.
18. Boyko EJ, de Courten M, Zimmet PZ, Chitson P, Tuomilehto J, Alberti KG. Features of the metabolic syndrome predict higher risk of diabetes and impaired glucose tolerance: a prospective study in Mauritius. Diabetes Care 2000 23 : 1242 1248.
19. Li N, Tuomilehto J, Dowse G, Zimmet P, Gareeboo H, Chitson P et al. Prevalence and medical care of hypertension in four ethnic groups in the newly-industrialized nation of Mauritius. J Hypertension 1991 9 : 859 866.
20. Soeldner J, Slone D. Critical variables in radioimmunoassay of serum insulin using the double antibody technique. Diabetes 1965 14 : 771 779.
21. Dowse G, Zimmet P, Gareeboo H, Alberti K, Tuomilehto J, Finch C et al. Abdominal obesity and physical inactivity as risk factors for NIDDM and impaired glucose tolerance in Indian, Creole and Chinese Mauritians. Diabetes Care 1991 14 : 271 282.
22. Levy J, Matthews D, Hermans M. Correct homeostatic model assessment (HOMA) evaluation uses the computer program. Diabetes Care 1998 21 : 2191 2192.
23. Hodge AM, Dowse GK, Gareeboo H, Tuomilehto J, Alberti KG, Zimmet PZ. Incidence, increasing prevalence, and predictors of change in obesity and fat distribution over 5 years in the rapidly developing population of Mauritius. Int J Obes Relat Metab Disord 1996 20 : 137 146.
24. Ford ES. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care 2005 28 : 1769 1778.
25. Dekker JM, Girman C, Rhodes T, Nijpels G, Stehouwer CD, Bouter LM et al. Metabolic syndrome and 10-year cardiovascular disease risk in the Hoorn Study. Circulation 2005 112 : 666 673.
26. McNeill AM, Rosamond WD, Girman CJ, Golden SH, Schmidt MI, East HE et al. The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study. Diabetes Care 2005 28 : 385 390.
27. Qiao Q. Comparison of different definitions of the metabolic syndrome in relation to cardiovascular mortality in European men and women. Diabetologia 2006 49 : 2837 2846.
28. Engelgau MM, Colagiuri S, Ramachandran A, Borch-Johnsen K, Narayan KM. Prevention of type 2 diabetes: issues and strategies for identifying persons for interventions. Diabetes Technol Ther 2004 6 : 874 882.
29. Lindstrom J, Tuomilehto J. The diabetes risk score: a practical tool to predict type 2 diabetes risk. Diabetes Care 2003 26 : 725 731.
30. Aekplakorn W, Bunnag P, Woodward M, Sritara P, Cheepudomwit S, Yamwong S et al. A risk score for predicting incident diabetes in the Thai population. Diabetes Care 2006 29 : 1872 1877.